Pharmaceutical Commerce - October 2009

FDA counters that the PMC program balances drug efficacy study with patient need

Annual surveys rank public companies by environmental, social criteria

Suspicious Order Monitoring (SOMLink) tracks ordering history with statistical analysis of baseline activity

The desire to compare drugs’ efficacy is shifting from a purely medical decision to a financial one

Globaltrackandtrace.org will try to build industry consensus on pharma security, traceability

European Court of Justice affirms a lower-court decision in a case dating to 1998

Though stem cells and other regenerative medicine techniques hold enormous promise, they also face an equally large set of obstacles, ranging from research funding to reimbursement

With new serialization-software release, Systech promotes ‘near-line’ applications

CDC is depending on a new distribution process for ‘the largest vaccine distribution in history’

At 28% pharmaceutical sales, chain pharmacy still represents the single largest channel for delivering prescriptions to patients

Conventional training of sales forces is being complemented by executive-level training for corporate compliance

A collaborative working relationship gives launch day a better chance at success

ICANN asserts independence from worldwide governments

MarkMonitor sees 23% growth in offshore business exchanges for bulk pharmaceuticals and APIs